EvoDenovo - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeEvoDenovo
EvoDenovo logo

EvoDenovo

0 followers

About EvoDenovo

EvoDenovo is a biotechnology company developing novel therapies for opioid use disorder by targeting the underlying mechanism of opioid withdrawal symptoms. They aim to provide patients and clinicians with safe, effective analgesic options that do not carry the addiction risks of opioid medications.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Jeff Leighton

Drug Development VP

Sid Labed

Chief Executive Officer (CEO)

Ira Kalfus

Chief Medical Officer (CMO)

Key Facts

HQ Location

United States

Founded

2020

Employees

1 - 10

Status

Private

Website

https://evodenovo.us